Endpoints News 2 juin 2026 FDA details flexibilities for new cell and gene therapies to leverage past data
FierceBiotech 2 juin 2026 ASCO: Roche, head held high, details oral SERD's first-line flop in breast cancer
GE HealthCare 2 juin 2026 GE HealthCare to Showcase Latest Technologies, AI-enabled Workflows - Imaging Technology News
Roche Media 2 juin 2026 ASCO: Roche, head held high, details oral SERD's first-line flop in breast cancer - Fierce Biotech
Harvard Bioscience 2 juin 2026 Harvard Bioscience stock (US4169061052): Nasdaq-listed share extends early-June rebound - AD HOC NEWS
BioPharma Dive 2 juin 2026 Fulcrum exploring a potential sale after FDA sidelined its sickle cell drug
Endpoints News 2 juin 2026 What’s next for VEGF? #ASCO26 offered clues, but answers will have to wait
Thermo Fisher 2 juin 2026 Mettler-Toledo International vs Thermo Fisher Scientific: Which Is the Stronger Buy Today? - Trefis
Merck & Co. 2 juin 2026 Merck shrinks headcount by 88 in New Jersey as $3B cost-cutting scheme advances - Fierce Pharma
FierceBiotech 2 juin 2026 Travere scales Everest with $1.1B deal for BTK inhibitor aimed at rare kidney diseases